SCHEMBL9887646

SCHEMBL9887646

CC(=O)[C@@H]1CCCC[C@@H]1C(=O)N(N)CCN1CCCC1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ HRH3 Q9Y5N1 5/20 0.34
▸ NPC1 O15118 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ TP53 P04637 1/20 0.32
▸ CHRM2 P08172 3/20 0.32
▸ CHRM4 P08173 3/20 0.32
▸ CHRM5 P08912 3/20 0.32
▸ CHRM1 P11229 3/20 0.32
▸ CHRM3 P20309 3/20 0.32
▸ MAPT P10636 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ SIGMAR1 Q99720 1/20 0.32
▸ BCHE P06276 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9887647 1.00 L3MBTL1 (0.34) L3MBTL1HRH3NPC1LMNAMAPK1
SCHEMBL14980975 1.00 L3MBTL1 (0.34) L3MBTL1HRH3NPC1LMNAMAPK1
SCHEMBL21974892 0.99 L3MBTL1 (0.37) L3MBTL1HRH3NPC1LMNAMAPK1
SCHEMBL23020573 0.99 L3MBTL1 (0.37) L3MBTL1HRH3NPC1LMNAMAPK1
SCHEMBL20879992 0.90 CYP1A2 (0.37) L3MBTL1HRH3NPC1MAPK1TP53
SCHEMBL12900874 0.90 CYP1A2 (0.37) L3MBTL1HRH3NPC1MAPK1TP53
SCHEMBL23955947 0.89 SIGMAR1 (0.36) CHRM5CHRM3MAPTALDH1A1SIGMAR1
SCHEMBL20879964 0.89 KMT2A (0.38) TP53MAPTALDH1A1
SCHEMBL23955948 0.89 SIGMAR1 (0.36) CHRM5CHRM3MAPTALDH1A1SIGMAR1
SCHEMBL24098133 0.89 SIGMAR1 (0.41) HRH3CYP1A2ALDH1A1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3050576-B1 PEGYLATED RECOMBINANT HUMAN GROWTH HORMONE COMPOUNDS ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S (DK) 2021-03-31 — — EP disclosed
EP-2237799-B1 PRODRUG COMPRISING A SELF-CLEAVABLE LINKER ASCENDIS PHARMA AS (DK) 2019-04-10 — — EP disclosed
EP-2512450-B1 DRY GROWTH HORMONE COMPOSITION TRANSIENTLY LINKED TO A POLYMER CARRIER ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S (DK) 2018-02-07 — — EP disclosed
WO-2013053856-A1 PREVENTION AND TREATMENT OF OCULAR CONDITIONS ASCENDIS PHARMA A/S (DK) 2013-04-18 — — WO disclosed
WO-2013024048-A1 POLYMERIC HYPERBRANCHED CARRIER-LINKED PRODRUGS ASCENDIS PHARMA A/S (DK) 2013-02-21 — — WO disclosed
WO-2013024047-A1 HIGH-LOADING WATER-SOLUBLE CARRIER-LINKED PRODRUGS ASCENDIS PHARMA A/S (DK) 2013-02-21 — — WO disclosed
WO-2013024049-A1 PROTEIN CARRIER-LINKED PRODRUGS ASCENDIS PHARMA A/S (DK) 2013-02-21 — — WO disclosed
WO-2011073234-A9 DRY GROWTH HORMONE COMPOSITION TRANSIENTLY LINKED TO A POLYMER CARRIER ASCENDIS PHARMA AS (DK) 2012-06-07 — — WO disclosed
WO-2011073234-A2 GROWTH HORMONE COMPOSITION ASCENDIS PHARMA AS (DK) 2011-06-23 — — WO disclosed
WO-2010100220-A1 INTERFERON ALPHA CARRIER PRODRUGS ASCENDIS PHARMA AS (DK) 2010-09-10 — — WO disclosed
WO-2009133137-A2 PEGYLATED RECOMBINANT HUMAN GROWTH HORMONE COMPOUNDS ASCENDIS PHARMA AS (DK) 2009-11-05 — — WO disclosed
WO-2009095479-A2 PRODRUG COMPRISING A SELF-CLEAVABLE LINKER ASCENDIS PHARMA AS (DK) 2009-08-06 — — WO disclosed
Send feedback